Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP
Successful translation of findings derived from preclinical studies into effective therapies is
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP
O Bucur, B Pennarun, AL Stancu… - Apoptosis: An …, 2013 - search.proquest.com
Successful translation of findings derived from preclinical studies into effective therapies is
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
[PDF][PDF] Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP
O Bucur, B Pennarun, AL Stancu, M Nadler… - Apoptosis, 2013 - researchgate.net
Successful translation of findings derived from preclinical studies into effective therapies is
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP
O Bucur, B Pennarun, AL Stancu, M Nadler, MS Muraru… - Apoptosis, 2013 - infona.pl
Successful translation of findings derived from preclinical studies into effective therapies is
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP
O Bucur, B Pennarun, AL Stancu… - Apoptosis: an …, 2013 - pubmed.ncbi.nlm.nih.gov
Successful translation of findings derived from preclinical studies into effective therapies is
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP.
O Bucur, B Pennarun, AL Stancu, M Nadler… - … on Programmed Cell …, 2013 - europepmc.org
Successful translation of findings derived from preclinical studies into effective therapies is
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …
critical in biomedical research. Lack of robustness and reproducibility of the preclinical data …